Word

Status

Pending

Status Code

686

Status Date

Tuesday, March 19, 2024

Serial Number

79359852

Mark Type

2000

Filing Date

Friday, August 19, 2022

Published for Opposition

Tuesday, March 19, 2024

Trademark Owner History

Sumitomo Pharma Co., Ltd. - Owner At Publication

Classifications

9 Calculating machines, data processing equipment, computers; downloadable computer software for data aggregation automation, database creation, data analysis, data reporting and data visualization; downloadable computer software for providing, analyzing and generating reports; downloadable computer software for data processing; electronic apparatus, electronic equipment, downloadable computer software and programs for the capture, collection, conversion, analysis, communication, processing, receiving, recording, storage and transmission of data, images and information; electronic apparatus, electronic equipment, downloadable computer software and programs for the conversion, analysis, processing, storage and transmission of artificial intelligence; downloadable computer software for database integration; downloadable computer software for creating searchable databases of information and data; downloadable software for analytics in the fields of healthcare, pharmaceuticals, biomedicine, pharmaceutical and biomedical research and development, and for clinical trial and post-market trial data; downloadable computer software featuring electronic computer databases of pharmaceuticals, biomedical research in support of data analysis and for clinical trial and post-market trial data; downloadable computer search engine software for compiling, accessing and providing updated scientific, medical, pharmaceutical and clinical information, and news information of general interest

36 Financial analysis; financial consulting; financial valuations and forecasting; financial analysis of statistics and data; financial analysis of investments in pharmaceutical and biomedical research and development, and clinical and post-market trials; financial evaluation, tracking, analysis, forecasting, consultancy, advisory and research services relating to healthcare, pharmaceuticals, biomedicine, pharmaceutical and biomedical research and development, and clinical and post-market trials

35 Advertising services; business management; business administration; providing office functions; business research services; business information services; market research; provision of market research information; data processing services; analysis of business data; statistical analysis and reporting services using artificial intelligence and machine learning for business purposes in the pharmaceutical and biomedical fields; business analysis and statistical analysis of healthcare data, pharmaceuticals, biomedical research, and for clinical trial and post-market data, all the foregoing for business purposes; systematization of data in computer databases; compilation of data for business analysis purposes, namely, compilation of information into computer databases for business data analysis purposes in the fields of healthcare, pharmaceuticals, biomedicine, pharmaceutical and biomedical research and development, clinical trials and post-market data; professional business data analysis and consultancy and statistical analysis for business purposes in the fields of healthcare, pharmaceuticals, biomedicine, clinical trials, epidemiological research, pharmacoepidemiological research, post-market trials and research evaluating epidemiological outcomes

42 Scientific and technological services, namely, data aggregation automation, database creation, data analysis, data reporting and data visualization in the field of healthcare, pharmaceuticals, biomedical research, and for clinical trial and post-marketing and research and design relating thereto; analysis of technical data by computers, namely, data automation and collection service using proprietary software to evaluate, analyze and collect data, providing use of online non-downloadable software for analyzing data; pharmaceutical, biomedical, and biological therapeutic research services; research in the field of pharmaceutical and biologic therapeutic preparations; pharmaceutical and biopharmaceutical research and development; providing scientific research information in the field of pharmaceuticals, biomedicine, clinical trials and post-market trials; cloud computing featuring software for use in data aggregation automation, database creation, data analysis, data reporting and data visualization; providing temporary use of online non-downloadable computer software featuring electronic computer databases of pharmaceuticals, biomedicine, pharmaceutical and biopharmaceutical research and development, medical information, clinical trial and post-market trial data for data analysis, data reporting and data visualization; providing temporary use of online non-downloadable computer software for research in the field of pharmaceuticals and biopharmaceuticals; providing temporary use of online non-downloadable computer software for compiling, accessing, controlling, managing and providing updated scientific, pharmaceutical, medical and clinical information, and news information of general interest; providing temporary use of non-downloadable software applications accessible via a web site for data analytics, financial analytics and risk management for use in the fields of pharmaceutical and biomedical research and development, clinical trials, and the provision of medical and healthcare services

The mark consists of adjoining incomplete polygons appearing as stylized molecules.

Trademark Events

Mar 19, 2024

Official Gazette Publication Confirmation E-Mailed

Mar 19, 2024

Published For Opposition

Feb 28, 2024

Notification Of Notice Of Publication E-Mailed

Feb 28, 2024

Official Gazette Publication Confirmation E-Mailed

Feb 13, 2024

Approved For Pub - Principal Register

Jan 19, 2024

Teas/Email Correspondence Entered

Jan 18, 2024

Correspondence Received In Law Office

Jan 18, 2024

Teas Response To Office Action Received

Aug 15, 2023

Refusal Processed By Ib

Jul 21, 2023

Non-Final Action Mailed - Refusal Sent To Ib

Jul 21, 2023

Refusal Processed By Mpu

Jun 15, 2023

Non-Final Action (Ib Refusal) Prepared For Review

Jun 14, 2023

Non-Final Action Written

Jun 7, 2023

Assigned To Examiner

Jan 13, 2023

Application Filing Receipt Mailed

Jan 9, 2023

New Application Office Supplied Data Entered

Jan 6, 2023

Sn Assigned For Sect 66a Appl From Ib